Published in Arthritis Res Ther on August 11, 2004
Electro-acupuncture at acupoint ST36 reduces inflammation and regulates immune activity in Collagen-Induced Arthritic Mice. Evid Based Complement Alternat Med (2006) 1.40
Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Arthritis Res Ther (2006) 1.32
Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis. J Immunol (2008) 1.10
Defective generation of a humoral immune response is associated with a reduced incidence and severity of collagen-induced arthritis in microsomal prostaglandin E synthase-1 null mice. J Immunol (2008) 0.92
B Cell in Autoimmune Diseases. Scientifica (Cairo) (2012) 0.90
The value of animal models in predicting genetic susceptibility to complex diseases such as rheumatoid arthritis. Arthritis Res Ther (2009) 0.88
Complementary and alternative medicine use in rheumatoid arthritis: proposed mechanism of action and efficacy of commonly used modalities. Rheumatol Int (2009) 0.82
Destructive effects of murine arthritogenic antibodies to type II collagen on cartilage explants in vitro. Arthritis Res Ther (2005) 0.80
ASC plays a role in the priming phase of the immune response to type II collagen in collagen-induced arthritis. Rheumatol Int (2011) 0.78
Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis. Biomed Res Int (2014) 0.76
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 111.05
Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum (1986) 2.56
Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol Rev (1990) 2.24
Isolation and characterization of the cyanogen bromide peptides from the alpha 1(II) chain of bovine and human cartilage collagen. Biochemistry (1973) 2.01
Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum (1989) 1.95
Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum (1986) 1.90
The KRN mouse model of inflammatory arthritis. Springer Semin Immunopathol (2003) 1.67
Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum (1996) 1.52
Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand J Immunol (1990) 1.51
Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum (1990) 1.46
Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum (1994) 1.44
Type II collagen-induced arthritis. Studies with purified anticollagen immunoglobulin. Arthritis Rheum (1983) 1.42
The cyanogen bromide peptides of bovine soluble and insoluble collagens. I. Characterization of peptides from soluble type I collagen by sodium dodecylsulphate polyacrylamide gel electrophoresis. Connect Tissue Res (1976) 1.39
Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse. Arthritis Rheum (2002) 1.39
Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmune connective tissue diseases, and chronic inflammatory syndromes. Ann Rheum Dis (1988) 1.26
Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis. Ann Rheum Dis (1987) 1.19
Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis. Arthritis Rheum (1987) 1.14
Mechanisms of disruption of the articular cartilage surface in inflammation. Neutrophil elastase increases availability of collagen type II epitopes for binding with antibody on the surface of articular cartilage. J Clin Invest (1991) 1.10
Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid arthritis. Arthritis Rheum (1981) 1.05
Induction of erosive arthritis in mice after passive transfer of anti-type II collagen antibodies. Agents Actions (1988) 0.98
Antibodies to types I, II, IX, and XI collagen in the serum of patients with rheumatic diseases. Arthritis Rheum (1988) 0.97
The B cell repertoire of patients with rheumatoid arthritis. II. Increased frequencies of IgG+ and IgA+ B cells specific for mycobacterial heat-shock protein 60 or human type II collagen in synovial fluid and tissue. Arthritis Rheum (1997) 0.95
Antibodies to type II collagen and HLA disease susceptibility markers in rheumatoid arthritis. Arthritis Rheum (1999) 0.95
The diagnostic significance of anti-type II collagen antibody assay in rheumatoid arthritis. Int Orthop (1992) 0.90
Diversity of antibodies to type II collagen in patients with rheumatoid arthritis: detection by binding to alpha-chains and to cyanogen bromide peptides. Br J Rheumatol (1990) 0.90
Disappearing collagen antibodies in rheumatoid arthritis. Lancet (1985) 0.89
Specificity of antibodies to type II collagen in early rheumatoid arthritis. J Rheumatol (1994) 0.88
Collagen mimetics. Biopolymers (1998) 0.87
Identification of antibody epitopes within the CB-11 peptide of type II collagen. I: Detection of antibody binding sites by epitope scanning. Autoimmunity (1991) 0.86
IgG subclasses of antibodies to type II collagen in rheumatoid arthritis differ from those in systemic lupus erythematosus and other connective tissue diseases. J Rheumatol (1997) 0.86
Collagen antibodies in juvenile arthritis and adult rheumatoid arthritis: differences in levels and type-specificity. J Rheumatol (1988) 0.84
Physicochemical and immunological studies of the renatured alpha 1(II) chains and isolated cyanogen bromide peptides of type II collagen. Coll Relat Res (1985) 0.82
Epitope specificity of antibodies to type II collagen in rheumatoid arthritis and systemic lupus erythematosus. Rheumatol Int (1992) 0.81
IgG subclass distribution of antinative type II collagen and antidenatured type II collagen antibodies in patients with rheumatoid arthritis. J Rheumatol (1988) 0.80
Antibodies to type II collagen in SLE: a role in the pathogenesis of deforming arthritis? Immunol Cell Biol (1990) 0.78
The effect of HLA-DRB1 disease susceptibility markers on the expression of RA. Scand J Rheumatol (1997) 0.77
Immunosusceptibility genes in rheumatoid arthritis. Hum Immunol (1996) 0.77
The causes of primary biliary cirrhosis: Convenient and inconvenient truths. Hepatology (2008) 2.32
Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol (2006) 2.18
NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med (2006) 2.16
Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology (2009) 2.11
Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. Hepatology (2008) 2.05
IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology (2006) 1.91
Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol (2004) 1.57
GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat Struct Mol Biol (2007) 1.56
Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology (2009) 1.55
Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology (2008) 1.45
IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun (2006) 1.43
Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun (2006) 1.41
From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol (2005) 1.22
B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology (2008) 1.17
The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc Natl Acad Sci U S A (2008) 1.15
Autophagy: highlighting a novel player in the autoimmunity scenario. J Autoimmun (2007) 1.12
COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity. Diabetes (2008) 1.11
Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun (2007) 1.07
Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies. J Autoimmun (2011) 1.06
CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis. J Autoimmun (2008) 1.04
CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis. Hepatology (2010) 1.04
The immunological milieu of the liver. Semin Liver Dis (2007) 1.03
B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice. Hepatology (2009) 1.03
Improving the estimation of mealtime insulin dose in adults with type 1 diabetes: the Normal Insulin Demand for Dose Adjustment (NIDDA) study. Diabetes Care (2011) 1.00
Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology (2014) 0.98
AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology (2007) 0.94
The autoimmunity of primary biliary cirrhosis and the clonal selection theory. Immunol Cell Biol (2010) 0.93
Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation. Arthritis Rheum (2008) 0.92
Molecular characterization of a disease associated conformational epitope on GAD65 recognised by a human monoclonal antibody b96.11. Mol Immunol (2006) 0.92
Autoimmune epitopes: autoepitopes. Autoimmun Rev (2004) 0.89
A tribute to an outstanding immunologist - Ian Reay Mackay. J Autoimmun (2008) 0.89
Requirement of multiple phage displayed peptide libraries for optimal mapping of a conformational antibody epitope on CCR5. J Immunol Methods (2005) 0.87
An arthritogenic monoclonal antibody to type II collagen, CII-C1, impairs cartilage formation by cultured chondrocytes. Immunol Cell Biol (2004) 0.86
Structural determinants of GAD antigenicity. Mol Immunol (2009) 0.85
Autoantibodies to the transcriptional factor SOX13 in primary biliary cirrhosis compared with other diseases. J Autoimmun (2002) 0.84
Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cells. Arthritis Rheum (2005) 0.84
Autoimmune gastritis: historical antecedents, outstanding discoveries, and unresolved problems. Int Rev Immunol (2005) 0.84
Retracted Dominant suppression of inflammation by glycan-hydrolyzed IgG. Proc Natl Acad Sci U S A (2013) 0.83
Measurement of antibodies to collagen II by inhibition of collagen fibril formation in vitro. J Immunol Methods (2004) 0.83
An analysis of the cross-reactivity of autoantibodies to GAD65 and GAD67 in diabetes. PLoS One (2011) 0.82
The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008. Isr Med Assoc J (2008) 0.81
BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus. IUBMB Life (2012) 0.81
Destructive effects of murine arthritogenic antibodies to type II collagen on cartilage explants in vitro. Arthritis Res Ther (2005) 0.80
Enzymatic characterization of a recombinant isoform hybrid of glutamic acid decarboxylase (rGAD67/65) expressed in yeast. J Biotechnol (2002) 0.80
What's in a name? Experimental encephalomyelitis: 'allergic' or 'autoimmune'. J Neuroimmunol (2010) 0.80
Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry. Immunol Cell Biol (2007) 0.79
Collagen of articular cartilage: the neglected autoantigen of rheumatoid arthritis. J Rheumatol (2008) 0.79
GAD65 as a prototypic autoantigen. J Autoimmun (2008) 0.79
Inflammatory bowel disease: beyond the boundaries of the bowel. Expert Rev Gastroenterol Hepatol (2011) 0.79
Type II collagen-specific antibodies induce cartilage damage in mice independent of inflammation. Arthritis Rheum (2013) 0.79
Autoantibody heritability in thyroiditis: IgG subclass contributions. Autoimmunity (2010) 0.78
Closer association of IA-2 humoral autoreactivity with HLA DR3/4 than DQB1*0201/*0302 in Korean T1D patients. Ann N Y Acad Sci (2004) 0.78
Characterisation of an autoreactive conformational epitope on GAD65 recognised by the human monoclonal antibody b78 using a combination of phage display, in vitro mutagenesis and molecular modelling. J Autoimmun (2006) 0.78
A diabetes-related epitope of GAD65: a major diabetes-related conformational epitope on GAD65. Ann N Y Acad Sci (2003) 0.77
Genetic susceptibility to chronic hepatitis B virus infection. J Gastroenterol Hepatol (2006) 0.77
Chemical changes demonstrated in cartilage by synchrotron infrared microspectroscopy in an antibody-induced murine model of rheumatoid arthritis. J Biomed Opt (2011) 0.77
Fashioning the immunological self: the biological individuality of F. Macfarlane Burnet. J Hist Biol (2014) 0.76
Gut reactions--from celiac affection to autoimmune model. N Engl J Med (2014) 0.76
Specific antibody protection of the extracellular cartilage matrix against collagen antibody-induced damage. Arthritis Rheum (2010) 0.76
The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera. Ann N Y Acad Sci (2002) 0.76
Toxic type 1 diabetes. Rev Endocr Metab Disord (2003) 0.75
Heritability of levels of autoantibodies using the method of plotting regression of offspring on midparent (ROMP). Autoimmunity (2005) 0.75
Two monoclonal antibodies to precisely the same epitope of type II collagen select non-crossreactive phage clones by phage display: implications for autoimmunity and molecular mimicry. Mol Immunol (2004) 0.75
Amino acids critical for binding of autoantibody to an immunodominant conformational epitope of the pyruvate dehydrogenase complex subunit E2: identification by phage display and site-directed mutagenesis. Mol Immunol (2005) 0.75